2026. COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW. Vietnam Journal of Community Medicine. 67, 10 (Oct. 2026). DOI:https://doi.org/10.52163/yhc.v67i10.6921.